Muthusamy Shanmugam - Net Worth and Insider Trading
Muthusamy Shanmugam Net Worth
The estimated net worth of Muthusamy Shanmugam is at least $43 Million dollars as of 2024-11-13. Muthusamy Shanmugam is the HEAD OF R&D, COO-NOVITIUM OPS of ANI Pharmaceuticals Inc and owns about 706,272 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $43 Million. Details can be seen in Muthusamy Shanmugam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Muthusamy Shanmugam has not made any transactions after 2024-07-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Muthusamy Shanmugam
Muthusamy Shanmugam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Muthusamy Shanmugam owns 1 companies in total, including ANI Pharmaceuticals Inc (ANIP) .
Click here to see the complete history of Muthusamy Shanmugam’s form 4 insider trades.
Insider Ownership Summary of Muthusamy Shanmugam
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ANIP | ANI Pharmaceuticals Inc | 2024-07-18 | director & HEAD OF R&D & COO-NOVITIUM OPS |
Muthusamy Shanmugam Latest Holdings Summary
Muthusamy Shanmugam currently owns a total of 1 stock. Muthusamy Shanmugam owns 706,272 shares of ANI Pharmaceuticals Inc (ANIP) as of July 18, 2024, with a value of $43 Million.
Latest Holdings of Muthusamy Shanmugam
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANIP | ANI Pharmaceuticals Inc | 2024-07-18 | 706,272 | 61.10 | 43,153,219 |
Holding Weightings of Muthusamy Shanmugam
Muthusamy Shanmugam Form 4 Trading Tracker
According to the SEC Form 4 filings, Muthusamy Shanmugam has made a total of 26 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 1 buys and 25 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 2,743 shares on July 18, 2024, which brought Muthusamy Shanmugam around $170,066.
Insider Trading History of Muthusamy Shanmugam
- 1
Muthusamy Shanmugam Trading Performance
GuruFocus tracks the stock performance after each of Muthusamy Shanmugam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Muthusamy Shanmugam is -13.91%. GuruFocus also compares Muthusamy Shanmugam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Muthusamy Shanmugam within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Muthusamy Shanmugam's insider trading performs compared to the benchmark.
Performance of Muthusamy Shanmugam
Muthusamy Shanmugam Ownership Network
Ownership Network List of Muthusamy Shanmugam
Ownership Network Relation of Muthusamy Shanmugam
Muthusamy Shanmugam Owned Company Details
What does ANI Pharmaceuticals Inc do?
Who are the key executives at ANI Pharmaceuticals Inc?
Muthusamy Shanmugam is the director & HEAD OF R&D & COO-NOVITIUM OPS of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , SVP - CORP. DEV. & STRATEGY Chad Gassert , and SVP & GENERICS Ori Gutwerg .
ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary
Over the past 18 months, Muthusamy Shanmugam made 25 insider transaction in ANI Pharmaceuticals Inc (ANIP) with a net sale of 776,190. Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 3,000 shares made by Meredith Cook , a net sale of 200,000 shares made by Chad Gassert , and a net sale of 130,208 shares made by Nikhil Lalwani .
In summary, during the past 3 months, insiders sold 500 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 1,411,262 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,411,262 shares.
ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.
ANI Pharmaceuticals Inc Insider Transactions
Muthusamy Shanmugam Mailing Address
Above is the net worth, insider trading, and ownership report for Muthusamy Shanmugam. You might contact Muthusamy Shanmugam via mailing address: C/o Ani Pharmaceuticals, Inc., 210 Main Street West, Baudette Mn 56623.